Stephanie Thomas
Committee Management Specialist
Advisory Committee on Immunization Practices
Centers for Disease Control and Prevention
1600 Clifton Road NE, Mailstop H24-8
Atlanta, Georgia 30329-4027
RE: Docket No. CDC-2025-0017
Submitted electronically via regulations.gov
Dear Ms. Thomas,
The National Health Council (NHC) looks forward to the upcoming meeting of the Advisory Committee on Immunization Practices (ACIP), now set for April 15–16, 2025, following its earlier postponement, as it offers an important opportunity for public engagement on immunization issues that significantly impact individuals with chronic diseases and disabilities.
Created by and for patient organizations over 100 years ago, the NHC brings diverse organizations together to forge consensus and drive patient-centered health policy. We promote increased access to affordable, high-value, equitable, and sustainable health care. Made up of more than 170 national health-related organizations and businesses, the NHC’s core membership includes the nation’s leading patient organizations. Other members include health- related associations and nonprofit organizations including the provider, research, and family caregiver communities; and businesses and organizations representing biopharmaceuticals, devices, diagnostics, generics, and payers.
Our members understand firsthand the essential role immunizations play in protecting individuals with chronic conditions, who are often at greater risk of severe outcomes from vaccine-preventable diseases. Vaccination remains a cornerstone of preventive care, improving patient outcomes, enhancing quality of life, and helping to reduce the overall burden of disease. It is critical that ACIP’s deliberations and recommendations continue to be grounded in rigorous, evidence-based science to ensure that immunization policies remain focused on advancing public health and improving outcomes for patients, particularly those with chronic conditions.
We value opportunities for meaningful dialogue and collaboration with CDC and other stakeholders in shaping immunization policies that reflect the experiences and needs of the chronic disease community. Thank you for your continued commitment to patient and public health.
NHC Submits Comments to CDC on Upcoming ACIP Meeting
04/11/2025
NHC Submits Comments to CDC on Upcoming ACIP Meeting (PDF)
April 11, 2025
Stephanie Thomas
Committee Management Specialist
Advisory Committee on Immunization Practices
Centers for Disease Control and Prevention
1600 Clifton Road NE, Mailstop H24-8
Atlanta, Georgia 30329-4027
RE: Docket No. CDC-2025-0017
Submitted electronically via regulations.gov
Dear Ms. Thomas,
The National Health Council (NHC) looks forward to the upcoming meeting of the Advisory Committee on Immunization Practices (ACIP), now set for April 15–16, 2025, following its earlier postponement, as it offers an important opportunity for public engagement on immunization issues that significantly impact individuals with chronic diseases and disabilities.
Created by and for patient organizations over 100 years ago, the NHC brings diverse organizations together to forge consensus and drive patient-centered health policy. We promote increased access to affordable, high-value, equitable, and sustainable health care. Made up of more than 170 national health-related organizations and businesses, the NHC’s core membership includes the nation’s leading patient organizations. Other members include health- related associations and nonprofit organizations including the provider, research, and family caregiver communities; and businesses and organizations representing biopharmaceuticals, devices, diagnostics, generics, and payers.
Our members understand firsthand the essential role immunizations play in protecting individuals with chronic conditions, who are often at greater risk of severe outcomes from vaccine-preventable diseases. Vaccination remains a cornerstone of preventive care, improving patient outcomes, enhancing quality of life, and helping to reduce the overall burden of disease. It is critical that ACIP’s deliberations and recommendations continue to be grounded in rigorous, evidence-based science to ensure that immunization policies remain focused on advancing public health and improving outcomes for patients, particularly those with chronic conditions.
We value opportunities for meaningful dialogue and collaboration with CDC and other stakeholders in shaping immunization policies that reflect the experiences and needs of the chronic disease community. Thank you for your continued commitment to patient and public health.
Sincerely,
Randall L. Rutta
Chief Executive Officer